San Mateo, CA, United States of America

Erika Kristine Ross

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Erika Kristine Ross: Innovating Cardiac Dysfunction Treatments**

Introduction

Erika Kristine Ross, a talented inventor based in San Mateo, CA, has made significant contributions to the field of medicine with her innovative inventions. With a remarkable portfolio of six patents, Erika specializes in developing systems and methods aimed at treating cardiac dysfunctions and improving patient care through advanced neuromodulation techniques.

Latest Patents

Among her latest patents are groundbreaking systems and methods for treating cardiac dysfunction through peripheral nerve stimulation. This invention focuses on the treatment and prevention of cardiac dysrhythmias, such as atrial fibrillation, along with hypertension, utilizing noninvasive peripheral nerve stimulation. Another notable patent is the development of systems, methods, and devices for peripheral neuromodulation. This invention includes a wearable device equipped with an electrically conductive skin interface, designed to stimulate underlying nerves through a transcutaneous surface stimulator. This technology adapts to various user sizes and targets specific nerves while also incorporating patient autonomic nervous system activity for optimized stimulation.

Career Highlights

Throughout her career, Erika has worked with esteemed organizations like Cala Health, Inc. and the Wisconsin Alumni Research Foundation. Her involvement in these companies has allowed her to collaborate with some of the top minds in the field, pushing the boundaries of innovation in medical technology.

Collaborations

Erika's successful career has been marked by fruitful collaborations with esteemed colleagues including Samuel Richard Hamner and Kathryn H. Rosenbluth. These collaborations have contributed to the development of her innovative patents, as well as the advancement of medical treatments designed to enhance patient outcomes.

Conclusion

Erika Kristine Ross continues to be a leading force in the innovation of cardiac treatments through her inventive spirit and dedication to improving healthcare. With her array of patents and collaborative efforts, she is contributing to the evolution of medical technologies that have the potential to save lives and enhance the quality of patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…